APA (7th ed.) Citation

Nicholas Dopkins, William Becker, Kathryn Miranda, Mike Walla, Prakash Nagarkatti, & Mitzi Nagarkatti. (2021). Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Nicholas Dopkins, William Becker, Kathryn Miranda, Mike Walla, Prakash Nagarkatti, and Mitzi Nagarkatti. Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Nicholas Dopkins, et al. Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor. Frontiers Media S.A., 2021.